Skip to main content

Global Photon Counting CT Market Witness Rising Research and Clinical Validation at 20% CAGR 2030

 


The global photon counting computed tomography (PCCT) marketv is set to witness a CAGR of ~20% in the next 5 years. Superior image quality and resolution, radiation dose reduction aided by PCCT, rising burden of chronic diseases, technological advancements and AI integration, and increased research and clinical validation are some of the key factors driving the photon counting CT market. 

Photon-counting computed tomography (PCCT) is a novel technology that allows higher spatial resolution as compared to conventional CT techniques resulting in improved spatial resolution, enhanced tissue contrast, and minimized image noise while retaining energy specific information. Compared to conventional CT, it provides similar dose reduction, specific material differentiation, and reduced contrast resolution; making it highly desirable for advanced imaging of diagnostic value in oncology, cardiology, and neurology areas. Overall photon counting CT represents a significant leap in diagnostic imaging technology.

Click here to get our sample PDF report for Medical Devices market:
https://meditechinsights.com/photon-counting-computed-tomography-market/request-sample/

Superior image quality and resolution to drive market growth

The ability to provide superior image quality and resolution is a key factor contributing to the growth of the PCCT market because it will significantly improve diagnostic accuracy. PCCT technology utilizes advanced detectors that count individual X-ray photons and store their energy information. This yields greater spatial resolution and improved contrast-to-noise ratio compared to conventional CT systems, resulting in the superior depiction of small anatomical structures and subtle lesions, which is valuable when detecting early-stage cancers, cardiovascular abnormalities, and neurological disorders. The use of photon counting CT is likely to become more prevalent in clinical practice because of its ability to provide sharper and more defined images compared to conventional systems, thereby improving patient care, patient outcomes, and clinical confidence.

Increased research and clinical validation to boost market growth

Various large medical imaging device manufacturers like Siemens Healthineers, GE HealthCare, and Canon Medical Systems among others are realizing the transformative potential of the technology and hence actively investing in or developing PCCT systems. For instance, in 2021, Siemens Healthineers launched and received FDA approval for its Naeotom Alpha, world’s first commercially approved PCCT system, thus setting a benchmark and opening the market. In 2024, Canon Medical Systems Corporation and Canon Healthcare USA, Inc. entered into a research collaboration with Penn Medicine for speeding the development of PCCT. In 2020, GE Healthcare acquired Prismatic Sensors, a Swedish start-up company having expertise in photon counting detectors, to strengthen their position in this market. The increased participation by both established and new imaging companies is a major contributor to the growth of the PCCT market, as it is driving innovation, increasing accessibility and moving photon counting CT from a research innovation to a mainstream diagnostic modality.

Competitive Landscape Analysis

The global photon counting CT market is marked by the presence of established and emerging market players such as Siemens Healthineers AG; GE Healthcare; Canon Medical Systems Corporation; Koninklijke Philips N.V.; Shanghai United Imaging Healthcare Co., LTD; Samsung; and Hitachi; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

 Get PDF Report for Competitive Analysis:
https://meditechinsights.com/photon-counting-computed-tomography-market/request-sample/

Global Photon Counting Computed Tomography (CT) Market Segmentation

This report by Medi-Tech Insights provides the size of the global photon counting CT market at the regional- and country-level from 2023 to 2030. The report further segments the market based on type, application, and end user.

Market Size & Forecast (2023-2030), By Technology, USD Million

  • Single Detector PCCT
  • Dual-Detector PCCT
  • Multidetector PCCT

Market Size & Forecast (2023-2030), By Application, USD Million

  • Oncology
  • Cardiology
  • Neurology
  • Pulmonology
  • Others

Market Size & Forecast (2023-2030), By End User, USD Million

  • Hospitals
  • Diagnostic Imaging Centers
  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

 

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Cell Isolation Market projected to grow at 11% CAGR with R&D in oncology therapies by 2030

  The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030,  driven by rising investments in cell-based research, increasing adoption of cell therapies, and growing demand for biopharmaceutical production. Growth is further supported by technological advancements in isolation methods, increasing R&D activities in regenerative medicine, and expanding clinical applications for isolated cells.  Cell isolation is a fundamental process in life sciences and clinical research, involving the separation of specific cell types from complex biological samples. The market is expanding due to growing applications in stem cell research, cancer biology, immunology, and personalized medicine. Additionally, improvements in magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic technologies are making cell isolation more efficient, reproducible, and scalable. To request a free sample copy of this report,...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more